Interestingly, FNDC3B was overexpressed in metastatic HCC tissues (73.33%, 11/15) compared with primary HCCs (45.45%, 20/44) (p = 0.003) (Figure 3A–3B). This evidence concerns the gene FNDC3B and hepatocellular carcinoma.